We and others have previously reported that n-3 PUFAs, especially EPA, exerted antineuroinflammatory properties in vivo in animal models of Alzheimer’s disease, Parkinson’s disease, and IL-1β induced neuroinflammation [33,34]. The gene discussed is IL1B; the disease is early-onset autosomal dominant Alzheimer disease.